Related Experiment Video
Updated: Feb 20, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer
Yongsheng Li1, Nidhi Sahni2, Rita Pancsa3
1Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; College of Bioinformatics Science and Technology and Bio-Pharmaceutical Key Laboratory of Heilongjiang Province, Harbin Medical University, Harbin 150081, China.
Abstract:
It is increasingly appreciated that alternative splicing plays a key role in generating functional specificity and diversity in cancer. However, the mechanisms by which cancer mutations perturb splicing remain unknown. Here, we developed a network-based strategy, DrAS-Net, to investigate more than 2.5 million variants across cancer types and link somatic mutations with cancer-specific splicing events. We identified more than 40,000 driver variant candidates and their 80,000 putative splicing targets deregulated in 33 cancer types and inferred their functional impact. Strikingly, tumors with splicing perturbations show reduced expression of immune system-related genes and increased expression of cell proliferation markers. Tumors harboring different mutations in the same gene often exhibit distinct splicing perturbations. Further stratification of 10,000 patients based on their mutation-splicing relationships identifies subtypes with distinct clinical features, including survival rates. Our work reveals how single-nucleotide changes can alter the repertoires of splicing isoforms, providing insights into oncogenic mechanisms for precision medicine.
Insights
Cancer mutations alter gene splicing, impacting immune response and cell growth. This study links specific mutations to splicing changes, revealing new cancer subtypes and potential precision medicine targets.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Alternative splicing generates functional diversity crucial for cancer.
- Mechanisms linking cancer mutations to splicing alterations are largely unknown.
Purpose of the Study:
- To develop a network-based strategy to link somatic mutations with cancer-specific splicing events.
- To investigate the functional impact of mutation-driven splicing perturbations across cancer types.
Main Methods:
- Developed DrAS-Net, a network-based strategy.
- Analyzed over 2.5 million variants across 33 cancer types.
- Inferred functional impact of deregulated splicing targets.
Main Results:
- Identified over 40,000 driver variant candidates and 80,000 splicing targets.
- Observed reduced immune gene expression and increased proliferation markers in tumors with splicing perturbations.
- Found distinct splicing alterations for different mutations within the same gene.
- Stratified 10,000 patients into subtypes with distinct clinical features, including survival rates.
Conclusions:
- Single-nucleotide changes can significantly alter splicing isoform repertoires in cancer.
- Mutation-splicing relationships provide insights into oncogenic mechanisms.
- Findings support the development of precision medicine strategies targeting splicing alterations.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Pre-mRNA Processing: RNA Splicing
Induced Pluripotent Stem Cells
Somatic...

